{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:49:17Z","timestamp":1793317757347,"version":"4.5.0"},"reference-count":55,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T00:00:00Z","timestamp":1757462400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Biotechnol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1038\/s41587-025-02793-8","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T09:03:14Z","timestamp":1757494994000},"page":"1142-1153","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2"],"prefix":"10.1038","volume":"44","author":[{"given":"Yankai","family":"Chu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shishuang","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingyang","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huiling","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinyu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yueru","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chi","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoding","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongchen","family":"Mu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ding","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wentao","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengjin","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingxian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchuan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Man","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaqi","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiali","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lulu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheyi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siqi","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi Arial","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7807-6094","authenticated-orcid":false,"given":"Yun","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7006-4737","authenticated-orcid":false,"given":"Hu","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6787-0495","authenticated-orcid":false,"given":"Chong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huanwei","family":"Ru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-9046","authenticated-orcid":false,"given":"Li","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3839-5998","authenticated-orcid":false,"given":"Ximin","family":"Chi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8118-7019","authenticated-orcid":false,"given":"Fangjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daming","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moubin","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9354-5864","authenticated-orcid":false,"given":"Xianming","family":"Deng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2508-5413","authenticated-orcid":false,"given":"Hai","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,9,10]]},"reference":[{"key":"2793_CR1","doi-asserted-by":"publisher","first-page":"638","DOI":"10.1038\/s41568-021-00365-x","volume":"21","author":"B Dale","year":"2021","unstructured":"Dale, B. et al. Advancing targeted protein degradation for cancer therapy. Nat. Rev. Cancer 21, 638\u2013654 (2021).","journal-title":"Nat. Rev. Cancer"},{"key":"2793_CR2","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1038\/s41573-019-0047-y","volume":"18","author":"M Schapira","year":"2019","unstructured":"Schapira, M., Calabrese, M. F., Bullock, A. N. & Crews, C. M. Targeted protein degradation: expanding the toolbox. Nat. Rev. Drug Discov. 18, 949\u2013963 (2019).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2793_CR3","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1016\/j.chembiol.2021.04.011","volume":"28","author":"KTG Samarasinghe","year":"2021","unstructured":"Samarasinghe, K. T. G. & Crews, C. M. Targeted protein degradation: a promise for undruggable proteins. Cell Chem. Biol. 28, 934\u2013951 (2021).","journal-title":"Cell Chem. Biol."},{"key":"2793_CR4","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1038\/s41573-021-00371-6","volume":"21","author":"M B\u00e9k\u00e9s","year":"2022","unstructured":"B\u00e9k\u00e9s, M., Langley, D. R. & Crews, C. M. PROTAC targeted protein degraders: the past is prologue. Nat. Rev. Drug Discov. 21, 181\u2013200 (2022).","journal-title":"Nat. Rev. Drug Discov."},{"key":"2793_CR5","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1038\/nchembio.1858","volume":"11","author":"DP Bondeson","year":"2015","unstructured":"Bondeson, D. P. et al. Catalytic in vivo protein knockdown by small-molecule PROTACs. Nat. Chem. Biol. 11, 611\u2013617 (2015).","journal-title":"Nat. Chem. Biol."},{"key":"2793_CR6","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1038\/s41586-019-1722-1","volume":"575","author":"Z Li","year":"2019","unstructured":"Li, Z. et al. Allele-selective lowering of mutant HTT protein by HTT\u2013LC3 linker compounds. Nature 575, 203\u2013209 (2019).","journal-title":"Nature"},{"key":"2793_CR7","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1038\/s41586-020-2545-9","volume":"584","author":"SM Banik","year":"2020","unstructured":"Banik, S. M. et al. Lysosome-targeting chimaeras for degradation of extracellular proteins. Nature 584, 291\u2013297 (2020).","journal-title":"Nature"},{"key":"2793_CR8","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1038\/s41586-022-05235-6","volume":"610","author":"H Marei","year":"2022","unstructured":"Marei, H. et al. Antibody targeting of E3 ubiquitin ligases for receptor degradation. Nature 610, 182\u2013189 (2022).","journal-title":"Nature"},{"key":"2793_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-52685-9","volume":"15","author":"Y Zhou","year":"2024","unstructured":"Zhou, Y. et al. Development of folate receptor targeting chimeras for cancer selective degradation of extracellular proteins. Nat. Commun. 15, 8695 (2024).","journal-title":"Nat. Commun."},{"key":"2793_CR10","doi-asserted-by":"publisher","first-page":"7126","DOI":"10.1016\/j.cell.2024.10.015","volume":"187","author":"P Lu","year":"2024","unstructured":"Lu, P. et al. Selective degradation of multimeric proteins by TRIM21-based molecular glue and PROTAC degraders. Cell 187, 7126\u20137142.e20 (2024).","journal-title":"Cell"},{"key":"2793_CR11","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1021\/acs.biochem.8b00391","volume":"57","author":"AD Buhimschi","year":"2018","unstructured":"Buhimschi, A. D. et al. Targeting the C481S ibrutinib-resistance mutation in Bruton\u2019s tyrosine kinase using PROTAC-mediated degradation. Biochemistry 57, 3564\u20133575 (2018).","journal-title":"Biochemistry"},{"key":"2793_CR12","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1016\/j.chembiol.2015.05.009","volume":"22","author":"J Lu","year":"2015","unstructured":"Lu, J. et al. Hijacking the E3 ubiquitin ligase cereblon to efficiently target BRD4. Chem. Biol. 22, 755\u2013763 (2015).","journal-title":"Chem. Biol."},{"key":"2793_CR13","doi-asserted-by":"publisher","first-page":"941","DOI":"10.1021\/acs.jmedchem.8b01631","volume":"62","author":"X Han","year":"2019","unstructured":"Han, X. et al. Discovery of ARD-69 as a highly potent proteolysis targeting chimera (PROTAC) degrader of androgen receptor (AR) for the treatment of prostate cancer. J. Med. Chem. 62, 941\u2013964 (2019).","journal-title":"J. Med. Chem."},{"key":"2793_CR14","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.chembiol.2019.12.006","volume":"27","author":"M Zeng","year":"2020","unstructured":"Zeng, M. et al. Exploring targeted degradation strategy for oncogenic KRASG12C. Cell Chem. Biol. 27, 19\u201331.e6 (2020).","journal-title":"Cell Chem. Biol."},{"key":"2793_CR15","doi-asserted-by":"publisher","first-page":"10606","DOI":"10.1021\/acs.jmedchem.1c00895","volume":"64","author":"G Dong","year":"2021","unstructured":"Dong, G., Ding, Y., He, S. & Sheng, C. Molecular glues for targeted protein degradation: from serendipity to rational discovery. J. Med. Chem. 64, 10606\u201310620 (2021).","journal-title":"J. Med. Chem."},{"key":"2793_CR16","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1126\/science.1244851","volume":"343","author":"J Kr\u00f6nke","year":"2014","unstructured":"Kr\u00f6nke, J. et al. Lenalidomide causes selective degradation of IKZF1 and IKZF3 in multiple myeloma cells. Science 343, 301\u2013305 (2014).","journal-title":"Science"},{"key":"2793_CR17","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1038\/nature14610","volume":"523","author":"J Kr\u00f6nke","year":"2015","unstructured":"Kr\u00f6nke, J. et al. Lenalidomide induces ubiquitination and degradation of CK1\u03b1 in del(5q) MDS. Nature 523, 183\u2013188 (2015).","journal-title":"Nature"},{"key":"2793_CR18","doi-asserted-by":"publisher","first-page":"eaal3755","DOI":"10.1126\/science.aal3755","volume":"356","author":"T Han","year":"2017","unstructured":"Han, T. et al. Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. Science 356, eaal3755 (2017).","journal-title":"Science"},{"key":"2793_CR19","doi-asserted-by":"publisher","first-page":"1199","DOI":"10.1038\/s41589-020-0594-x","volume":"16","author":"C Mayor-Ruiz","year":"2020","unstructured":"Mayor-Ruiz, C. et al. Rational discovery of molecular glue degraders via scalable chemical profiling. Nat. Chem. Biol. 16, 1199\u20131207 (2020).","journal-title":"Nat. Chem. Biol."},{"key":"2793_CR20","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/nature18611","volume":"535","author":"ME Matyskiela","year":"2016","unstructured":"Matyskiela, M. E. et al. A novel cereblon modulator recruits GSPT1 to the CRL4CRBN ubiquitin ligase. Nature 535, 252\u2013257 (2016).","journal-title":"Nature"},{"key":"2793_CR21","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1126\/science.adk6129","volume":"385","author":"PY Ting","year":"2024","unstructured":"Ting, P. Y. et al. A molecular glue degrader of the WIZ transcription factor for fetal hemoglobin induction. Science 385, 91\u201399 (2024).","journal-title":"Science"},{"key":"2793_CR22","doi-asserted-by":"publisher","first-page":"10437","DOI":"10.1073\/pnas.95.18.10437","volume":"95","author":"T Clackson","year":"1998","unstructured":"Clackson, T. et al. Redesigning an FKBP\u2013ligand interface to generate chemical dimerizers with novel specificity. Proc. Natl Acad. Sci. USA 95, 10437\u201310442 (1998).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2793_CR23","doi-asserted-by":"publisher","first-page":"5498","DOI":"10.1039\/D2CS00197G","volume":"51","author":"A Domostegui","year":"2022","unstructured":"Domostegui, A., Nieto-Barrado, L., Perez-Lopez, C. & Mayor-Ruiz, C. Chasing molecular glue degraders: screening approaches. Chem. Soc. Rev. 51, 5498\u20135517 (2022).","journal-title":"Chem. Soc. Rev."},{"key":"2793_CR24","doi-asserted-by":"publisher","first-page":"eabd6263","DOI":"10.1126\/sciadv.abd6263","volume":"7","author":"V Koduri","year":"2021","unstructured":"Koduri, V. et al. Targeting oncoproteins with a positive selection assay for protein degraders. Sci. Adv. 7, eabd6263 (2021).","journal-title":"Sci. Adv."},{"key":"2793_CR25","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1038\/s41587-024-02164-9","volume":"42","author":"K Garber","year":"2024","unstructured":"Garber, K. The glue degraders. Nat. Biotechnol. 42, 546\u2013550 (2024).","journal-title":"Nat. Biotechnol."},{"key":"2793_CR26","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1038\/nrc3700","volume":"14","author":"Z Wang","year":"2014","unstructured":"Wang, Z., Liu, P., Inuzuka, H. & Wei, W. Roles of F-box proteins in cancer. Nat. Rev. Cancer 14, 233\u2013247 (2014).","journal-title":"Nat. Rev. Cancer"},{"key":"2793_CR27","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/12013","volume":"1","author":"AC Carrano","year":"1999","unstructured":"Carrano, A. C., Eytan, E., Hershko, A. & Pagano, M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat. Cell Biol. 1, 193\u2013199 (1999).","journal-title":"Nat. Cell Biol."},{"key":"2793_CR28","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/s41422-020-0372-z","volume":"31","author":"J Liu","year":"2021","unstructured":"Liu, J. et al. Skp2 dictates cell cycle-dependent metabolic oscillation between glycolysis and TCA cycle. Cell Res. 31, 80\u201393 (2021).","journal-title":"Cell Res."},{"key":"2793_CR29","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1016\/j.cell.2012.10.025","volume":"151","author":"CH Chan","year":"2012","unstructured":"Chan, C. H. et al. The Skp2-SCF E3 ligase regulates Akt ubiquitination, glycolysis, Herceptin sensitivity, and tumorigenesis. Cell 151, 913\u2013914 (2012).","journal-title":"Cell"},{"key":"2793_CR30","doi-asserted-by":"publisher","first-page":"1649","DOI":"10.1073\/pnas.0406789102","volume":"102","author":"H Huang","year":"2005","unstructured":"Huang, H. et al. Skp2 inhibits FOXO1 in tumor suppression through ubiquitin-mediated degradation. Proc. Natl Acad. Sci. USA 102, 1649\u20131654 (2005).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2793_CR31","doi-asserted-by":"publisher","first-page":"2069","DOI":"10.1093\/emboj\/19.9.2069","volume":"19","author":"K Nakayama","year":"2000","unstructured":"Nakayama, K. et al. Targeted disruption of Skp2 results in accumulation of cyclin E and p27Kip1, polyploidy and centrosome overduplication. EMBO J. 19, 2069\u20132081 (2000).","journal-title":"EMBO J."},{"key":"2793_CR32","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.semcancer.2020.01.013","volume":"67","author":"Z Cai","year":"2020","unstructured":"Cai, Z. et al. The Skp2 pathway: a critical target for cancer therapy. Semin. Cancer Biol. 67, 16\u201333 (2020).","journal-title":"Semin. Cancer Biol."},{"key":"2793_CR33","doi-asserted-by":"publisher","first-page":"7034","DOI":"10.1038\/s41388-020-01481-y","volume":"39","author":"G Wang","year":"2020","unstructured":"Wang, G. et al. Her2 promotes early dissemination of breast cancer by suppressing the p38 pathway through Skp2-mediated proteasomal degradation of Tpl2. Oncogene 39, 7034\u20137050 (2020).","journal-title":"Oncogene"},{"key":"2793_CR34","doi-asserted-by":"publisher","first-page":"4149","DOI":"10.1158\/0008-5472.CAN-06-4484","volume":"67","author":"M Reichert","year":"2007","unstructured":"Reichert, M., Saur, D., Hamacher, R., Schmid, R. M. & Schneider, G. Phosphoinositide-3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res. 67, 4149\u20134156 (2007).","journal-title":"Cancer Res."},{"key":"2793_CR35","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1158\/0008-5472.CAN-04-1357","volume":"65","author":"EJ Andreu","year":"2005","unstructured":"Andreu, E. J. et al. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res. 65, 3264\u20133272 (2005).","journal-title":"Cancer Res."},{"key":"2793_CR36","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1084\/jem.20050559","volume":"202","author":"LM Sarmento","year":"2005","unstructured":"Sarmento, L. M. et al. Notch1 modulates timing of G1\u2013S progression by inducing SKP2 transcription and p27Kip1 degradation. J. Exp. Med. 202, 157\u2013168 (2005).","journal-title":"J. Exp. Med."},{"key":"2793_CR37","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1038\/s41375-019-0653-z","volume":"34","author":"S Rodriguez","year":"2020","unstructured":"Rodriguez, S. et al. Therapeutic targeting of the E3 ubiquitin ligase SKP2 in T-ALL. Leukemia 34, 1241\u20131252 (2020).","journal-title":"Leukemia"},{"key":"2793_CR38","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1016\/j.ccell.2017.04.004","volume":"31","author":"S Zhang","year":"2017","unstructured":"Zhang, S. et al. Hippo signaling suppresses cell ploidy and tumorigenesis through Skp2. Cancer Cell 31, 669\u2013684.e7 (2017).","journal-title":"Cancer Cell"},{"key":"2793_CR39","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nature02381","volume":"428","author":"W Wei","year":"2004","unstructured":"Wei, W. et al. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 428, 194\u2013198 (2004).","journal-title":"Nature"},{"key":"2793_CR40","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1038\/35050618","volume":"3","author":"P Connell","year":"2001","unstructured":"Connell, P. et al. The co-chaperone CHIP regulates protein triage decisions mediated by heat-shock proteins. Nat. Cell Biol. 3, 93\u201396 (2001).","journal-title":"Nat. Cell Biol."},{"key":"2793_CR41","doi-asserted-by":"publisher","first-page":"12847","DOI":"10.1073\/pnas.202365899","volume":"99","author":"W Xu","year":"2002","unstructured":"Xu, W. et al. Chaperone-dependent E3 ubiquitin ligase CHIP mediates a degradative pathway for c-ErbB2\/Neu. Proc. Natl Acad. Sci. USA 99, 12847\u201312852 (2002).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"2793_CR42","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/35042620","volume":"408","author":"BA Schulman","year":"2000","unstructured":"Schulman, B. A. et al. Insights into SCF ubiquitin ligases from the structure of the Skp1\u2013Skp2 complex. Nature 408, 381\u2013386 (2000).","journal-title":"Nature"},{"key":"2793_CR43","doi-asserted-by":"publisher","DOI":"10.1126\/science.adk4422","volume":"383","author":"JAM Mercer","year":"2024","unstructured":"Mercer, J. A. M. et al. Continuous evolution of compact protein degradation tags regulated by selective molecular glues. Science 383, eadk4422 (2024).","journal-title":"Science"},{"key":"2793_CR44","doi-asserted-by":"publisher","first-page":"3708","DOI":"10.7150\/thno.41677","volume":"10","author":"D Ma","year":"2020","unstructured":"Ma, D. et al. A cell-permeable peptide-based PROTAC against the oncoprotein CREPT proficiently inhibits pancreatic cancer. Theranostics 10, 3708\u20133721 (2020).","journal-title":"Theranostics"},{"key":"2793_CR45","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2021.109482","volume":"36","author":"W Xu","year":"2021","unstructured":"Xu, W. et al. Compartmentalization-aided interaction screening reveals extensive high-order complexes within the SARS-CoV-2 proteome. Cell Rep. 36, 109482 (2021).","journal-title":"Cell Rep."},{"key":"2793_CR46","doi-asserted-by":"publisher","first-page":"7327","DOI":"10.1021\/acs.chemrev.1c00293","volume":"122","author":"JL Bennett","year":"2022","unstructured":"Bennett, J. L., Nguyen, G. T. H. & Donald, W. A. Protein\u2013small molecule interactions in native mass spectrometry. Chem. Rev. 122, 7327\u20137385 (2022).","journal-title":"Chem. Rev."},{"key":"2793_CR47","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1016\/j.cell.2013.06.048","volume":"154","author":"CH Chan","year":"2013","unstructured":"Chan, C. H. et al. Pharmacological inactivation of Skp2 SCF ubiquitin ligase restricts cancer stem cell traits and cancer progression. Cell 154, 556\u2013568 (2013).","journal-title":"Cell"},{"key":"2793_CR48","doi-asserted-by":"publisher","first-page":"e2626","DOI":"10.1038\/cddis.2016.472","volume":"8","author":"ST Wang","year":"2017","unstructured":"Wang, S. T., Ho, H. J., Lin, J. T., Shieh, J. J. & Wu, C. Y. Simvastatin-induced cell cycle arrest through inhibition of STAT3\/SKP2 axis and activation of AMPK to promote p27 and p21 accumulation in hepatocellular carcinoma cells. Cell Death Dis. 8, e2626 (2017).","journal-title":"Cell Death Dis."},{"key":"2793_CR49","first-page":"1949","volume":"6","author":"J Su","year":"2016","unstructured":"Su, J., Zhou, X., Wang, L., Yin, X. & Wang, Z. Curcumin inhibits cell growth and invasion and induces apoptosis through down-regulation of Skp2 in pancreatic cancer cells. Am. J. Cancer Res. 6, 1949\u20131962 (2016).","journal-title":"Am. J. Cancer Res."},{"key":"2793_CR50","doi-asserted-by":"publisher","first-page":"5972","DOI":"10.1210\/en.2008-0408","volume":"149","author":"HC Huang","year":"2008","unstructured":"Huang, H. C., Way, T. D., Lin, C. L. & Lin, J. K. EGCG stabilizes p27kip1 in E2-stimulated MCF-7 cells through down-regulation of the Skp2 protein. Endocrinology 149, 5972\u20135983 (2008).","journal-title":"Endocrinology"},{"key":"2793_CR51","doi-asserted-by":"publisher","first-page":"46862","DOI":"10.1074\/jbc.M306340200","volume":"278","author":"ES Yang","year":"2003","unstructured":"Yang, E. S. & Burnstein, K. L. Vitamin D inhibits G1 to S progression in LNCaP prostate cancer cells through p27Kip1 stabilization and Cdk2 mislocalization to the cytoplasm. J Biol. Chem. 278, 46862\u201346868 (2003).","journal-title":"J Biol. Chem."},{"key":"2793_CR52","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbior.2023.100964","volume":"88","author":"AH Elahi","year":"2023","unstructured":"Elahi, A. H. et al. Targeted pharmacologic inhibition of S-phase kinase-associated protein 2 (SKP2) mediated cell cycle regulation in lung and other RB-related cancers: a brief review of current status and future prospects. Adv. Biol. Regul. 88, 100964 (2023).","journal-title":"Adv. Biol. Regul."},{"key":"2793_CR53","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.1158\/0008-5472.CAN-19-2400","volume":"80","author":"H Zhao","year":"2020","unstructured":"Zhao, H. et al. Targeted inhibition of the E3 ligase SCFSkp2\/Cks1 has antitumor activity in RB1-deficient human and mouse small-cell lung cancer. Cancer Res. 80, 2355\u20132367 (2020).","journal-title":"Cancer Res."},{"key":"2793_CR54","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1089\/adt.2011.0380","volume":"9","author":"M Jerabek-Willemsen","year":"2011","unstructured":"Jerabek-Willemsen, M., Wienken, C. J., Braun, D., Baaske, P. & Duhr, S. Molecular interaction studies using microscale thermophoresis. Assay Drug Dev. Technol. 9, 342\u2013353 (2011).","journal-title":"Assay Drug Dev. Technol."},{"key":"2793_CR55","doi-asserted-by":"crossref","unstructured":"Chu, Y. et al. A rapid imaging-based screen for induced-proximity degraders identifies a potent degrader of oncoprotein SKP2. Mendeley Data https:\/\/data.mendeley.com\/datasets\/vnbpprr393\/1 (2025).","DOI":"10.1038\/s41587-025-02793-8"}],"container-title":["Nature Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02793-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02793-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T18:03:24Z","timestamp":1784052204000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41587-025-02793-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,10]]},"references-count":55,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["2793"],"URL":"https:\/\/doi.org\/10.1038\/s41587-025-02793-8","relation":{},"ISSN":["1087-0156","1546-1696"],"issn-type":[{"value":"1087-0156","type":"print"},{"value":"1546-1696","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,9,10]]},"assertion":[{"value":"7 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In the version of the article initially published, in Supplementary Fig. 2b, the A549, vector and PC-3, vector and shSKP2#1 images were duplicated from Fig. 2g (the A549, vehicle; JHH7, vehicle and A549, SKPer1 images, respectively). Additionally, in Supplementary Fig. 2c, the HCC827, vector and shSKP2#1 images were also duplicated in Fig. 2g (the MDA-MB-231, vehicle and SKPer1 images). Supplementary Fig. 2 has been amended with the correct images. The new Supplementary information is now available alongside the online version of the article.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"H.J., D.X., Y.Y., S.C., Y.C. and H.F. are co-inventors of patent applications based on this study. H.J., Y.C., Y.X., C.W., W.J., Z.H., M.L., H.R. and J.M. hold equity in or are employees of Defandtx, which works on developing MGD drugs. The other authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}